Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Vanta Bioscience Limited, is an unlisted public company incorporated on 29 April, 2016. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 7.50 cr and the total paid-up capital is INR 6.31 cr.
Vanta Bioscience Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2020. It's EBITDA has increased by 32.07% over the previous year. At the same time, it's book networth has increased by 5.37%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2020 numbers.
13.59%
32.07%
40.97%
5.37%
1.19%
9.43%
2.89
4.28
1.4
1.05
2.17
-0.02
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(2)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | ||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|
| Solvency + | ||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | ||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | ||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | ||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | ||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | ||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 19.3 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Yogeswara Rao Danda | 00694803 | 6 years |
| Managing Director | Dopesh Raja Mulakala
Shareholder
|
01176660 | 9 years |
| Director | Mohan Krishna Mulakala
Shareholder
|
01448535 | 9 years |
| Director | Padmanabhuni Venkata Appaji | 02614167 | 8 years |
| Whole-time Director | Vyasmurti Madhavrao Shingatgeri
Shareholder
|
07728757 | 8 years |
| Director | Gonuguntla Kathyayani | 07824881 | 8 years |
| Kmp | Vidisha Vimal Hingu | <HIDDEN> | 2 years |
| Kmp | Venkata Sathya Murali Dokka | <HIDDEN> | 3 years |
| Kmp | Sangeetha Padam Choudhary | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ASSOCIATION FOR SCIENTIFIC PURSUITS FOR INNOVATIVE RESEARCH ENTERPRISES |
Active
|
0.0 | 1 | Telangana |
| NUTRIHUB TECHNOLOGY BUSINESS INCUBATOR STARTUPS CONFEDERATION |
Active
|
0.0 | 1 | Telangana |
| SARVOTHAM REMEDIES LIMITED |
Active
|
57.0 L | 1 | Telangana |
| SHREE COSMETICS LIMITED |
Active
|
4.0 Cr | 2 | Delhi |
| VANTA CLINICAL RESEARCH LIMITED |
Active
|
3.0 Cr | 1 | Telangana |
| CEBIS INDIA LIMITED |
Active
|
8.3 Cr | 1 | Telangana |
| SARVOTHAM SOLUTIONS LIMITED |
Active
|
22.7 L | 2 | Telangana |
| Sarvotham Hexis LLP |
Active
|
1.0 L | 1 | ng |
| SARVOTHAM CARE LIMITED |
Active
|
25.0 Cr | 2 | Telangana |
| SPECIFIC LABORATORIES PVT. LTD. |
Active
|
4.1 L | 1 | Telangana |
| SAI MED PHARMA SYSTEMS PRIVATE LIMITED |
Active
|
1.5 Cr | 1 | Telangana |
| MEENAXY LIFE SCIENCES LIMITED |
Strike Off
|
5.0 L | 1 | Telangana |
| VASUDHA PHARMA CHEM LIMITED |
Active
|
35.0 Cr | 1 | Telangana |
| NUUTJOB LIMITED |
Active
|
98.0 L | 1 | Gujarat |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| VANTA CLINICAL RESEARCH LIMITED | Telangana | 2018 | ₹ 3.0 Cr |
| CEBIS INDIA LIMITED | Telangana | 2018 | ₹ 8.3 Cr |
The incorporation date of VANTA BIOSCIENCE LIMITED is 29 April, 2016
The authorized share capital of VANTA BIOSCIENCE LIMITED is INR ₹ 7.5 Cr.
The paid-up capital of VANTA BIOSCIENCE LIMITED is INR ₹ 6.3 Cr.
The registered address of VANTA BIOSCIENCE LIMITED is NO.02/G/308/G NO.3/FF/SF/1-20-248 UMAJAY COMPLEX RASOOLPURA SECUNDERABAD Hyderabad Telangana - 500003
The CIN number of VANTA BIOSCIENCE LIMITED is L74999TG2016PLC109280.
Expand
Delete
Collapse
See
details
